Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-146.72M
↓ 137% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-61.85M
Historical baseline
PeriodValueYoY Change
2025$-146.72M-40.4%
2024$-104.51M-24.8%
2023$-83.73M-1.6%
2022$-82.43M-57.7%
2021$-52.27M-162.3%
2020$-19.92M-546.6%
2019$-3.08M-41.6%
2018$-2.18M-